ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionKestra Advisory Services, LLC
Latest Disclosed Ownership103,378 shares
Latest Disclosed Value $ 792,909
Kestra Advisory Services, LLC reports 15.07% increase in ownership of 26CA / ImmunityBio, Inc.

On April 30, 2026 - Kestra Advisory Services, LLC filed a 13F-HR form disclosing ownership of 103,378 shares of ImmunityBio, Inc. (DE:26CA) valued at $678,160 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 89,838 shares of ImmunityBio, Inc.. This represents a change in shares of 15.07% during the quarter. The current value of the position is $633,707 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F IMMUNITYBIO COM 45256X103 103,378 13,540 15.07 793 347.46 0.0030
2026-02-13 2025-12-31 13F IMMUNITYBIO COM 45256X103 89,838 27,938 45.13 178 16.45 0.0007
2025-11-14 2025-09-30 13F IMMUNITYBIO COM 45256X103 61,900 21,180 52.01 152 42.06 0.0007
2025-08-15 2025-06-30 13F IMMUNITYBIO COM 45256X103 40,720 1,820 4.68 108 -8.55 0.0005
2025-05-14 2025-03-31 13F IMMUNITYBIO COM 45256X103 38,900 1,880 5.08 117 24.47 0.0006
2025-02-10 2024-12-31 13F IMMUNITYBIO COM 45256X103 37,020 3,970 12.01 95 -22.95 0.0005
2024-11-13 2024-09-30 13F IMMUNITYBIO COM 45256X103 33,050 -970 -2.85 123 -43.26 0.0007
2024-08-14 2024-06-30 13F IMMUNITYBIO COM 45256X103 34,020 1,200 3.66 215 22.16 0.0012
2024-05-15 2024-03-31 13F IMMUNITYBIO COM 45256X103 32,820 6,020 22.46 176 31.34 0.0012
2024-02-14 2023-12-31 13F IMMUNITYBIO COM 45256X103 26,800 3,500 15.02 135 243.59 0.0011
2023-11-13 2023-09-30 13F IMMUNITYBIO COM 45256X103 23,300 -3,400 -12.73 39 -47.30 0.0004
2023-08-11 2023-06-30 13F IMMUNITYBIO COM 45256X103 26,700 26,700 74 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.